Evidence mapPaperPMID 39998770Full record

ArticleCurrent medical science2025

Insulin Resistance and Estimated 10-Year Risk of a First Hard Cardiovascular Event.

Zhen Yang, Jun-He Shi, Shan He

Abstract read
PubMed Publisher
In one paragraph

Article in Current medical science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Zhen YangChina Academy of Chinese Medical Sciences, Xiyuan Hospital, Beijing, 100091, China.
Jun-He ShiChina Academy of Chinese Medical Sciences, Xiyuan Hospital, Beijing, 100091, China.
Shan HeChina Academy of Chinese Medical Sciences, Wangjing Hospital, Beijing, 100102, China. heshan0709@126.com.ORCID http://orcid.org/0000-0002-0321-8975

Funding

Xiyuan Hospital XYZX0405-25
6 · The paper itself

Abstract

objectiveThis study aimed to investigate the association between insulin resistance and the risk of cardiovascular disease.

methodsA cross-sectional study including 2128 participants aged 40-79 years was conducted using data from the National Health and Nutrition Examination Survey from 1999 to 2018. The quantitative insulin sensitivity check index (QUICKI) and homeostasis model assessment of β-cell function (HOMA-β) were used as independent variables. The 10-year risk of a first hard atherosclerotic cardiovascular event was used as the dependent variable, with other potential confounding factors considered. Multivariate linear regression models and smooth curve fitting were used to assess the associations between insulin resistance and 10-year risk.

resultsA total of 2128 patients, comprising 1191 men and 937 women, were included in our analysis. The regression analyses revealed a negative correlation between the QUICKI score and the 10-year risk of a first hard atherosclerotic cardiovascular event [β = - 8.85, CI (- 15.77, - 1.93)] after adjusting for age, race, body mass index, systolic blood pressure, diastolic blood pressure, hypertension treatment, smoking, diabetes, and low-density lipoprotein cholesterol. Conversely, an increase in HOMA-β was associated with 10-year risk [β =  6.84, CI (0.45, 13.23)]. Gender-specific subgroup analysis indicated that the QUICKI had a β value of 0.077 (0.046, 0.108) for men and 0.080 (0.061, 0.094) for women.

conclusionThis study demonstrated that increased insulin resistance is linked to an increased risk of cardiovascular disease.

Indexed as

Cardiovascular DiseasesInsulin ResistanceAdultAgedBody Mass IndexCross-Sectional StudiesFemaleHumansMaleMiddle AgedNutrition SurveysRisk Factors10-year riskCross-sectional studyHOMA-βInsulin resistanceNHANESQUICKI

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.